Nasdaq Stock News

Commodities Soar As Ruble Routed, Tech Wrecked, & S&P Enters Correction Nasdaq is now down 5 straight days (and S&P down 4 straight) with today''s reflexive BTFD overnight gains ( Nasdaq was up 1.5% pre-open and ended down 2.5% ) evaporating as various headlines hit - all escalating tensions… Nasdaq is down 3.5% from last Friday''s (pre-Putin) close leading the rest of the majors lower. Notice that each time the algos tried to get us back to even from pre-Putin, a wave of selling hit... S&P in correction (down over 10% from its highs) and Small Caps - Russell 2000 - is in a bear market once again (down 20% from its highs)... Source: Bloomberg Mega-cap Tech, the FAAMG+T complex is now down almost 15% ytd with FB down 40%, TSLA down 25%, and MSFT down 15%. Source: Bloomberg Just a ''fleshwound'' right? S&P Breadth continues to weaken... Source: Bloomberg And Nasdaq breadth is a bloodbath!! The last time just 25% of Nasdaq companies traded above the 200DMA, the Nasdaq was 30% lower... Source: Bloomberg US corporate credit risk continues to surge...

FlexEnergy Green Solutions has withdrawn its plans to raise $20M through an initial public offering on the Nasdaq.

An investigation for investors in Anavex Life Sciences Corp. (NASDAQ:AVXL) shares over potential securities laws violations by Anavex Life Sciences Corp. was announced. San Diego, CA -- ( SBWIRE ) -- 02/23/2022 -- Anavex Life Sciences Corp. is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Anavex Life Sciences Corp. (NASDAQ: AVXL), have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Anavex Life Sciences Corp. regarding its business, its prospects and its operations were materially false and misleading at the time they were made. New York based Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Before the market opened on February 1, 2022, Anavex Life Sciences Corp. announced that a phase 3 trial of ANAVEX2-73 (blarcamesine) for Rett syndrome met primary and secondary endpoints.

Laser Photonics (LASE), a developer of industrial surface preparation and cleaning technologies, has filed to raise $15M through an initial public offering on the Nasdaq.

Canadas Algernon Pharmaceuticals (AGNPF) has filed to uplist its shares to Nasdaq and hold an initial public offering. Read more on Algernon''s proposed deal here.

The Gladstone Companies (GC), an asset management firm that oversees four publicly traded funds plus a SPAC, has filed to hold an initial public offering on Nasdaq.

POET Technologies (POETF) announced as the key next step in its Nasdaq listing process that it has determined to proceed with a 10-for-1 consolidation of its shares for meeting

Is a Bitcoin IRA Right For Your Retirement Plan? Nasdaq

China allows imports of some beef and mutton products from Chile Nasdaq

A potential decoupling scenario between Bitcoin (BTC) and the Nasdaq Composite can push BTC price to reach $100,000 within 24 months, according to Tuur

Bitcoin''s growth has quickly outpaced Nasdaq''s in the past ten years.

The FTX crypto exchange is now more valuable than Twitter, Nasdaq, and Deutsche Bank. It''s made 29-year-old Bankman-Fried worth more than $24 billion.

Read more about Nasdaq sinks into ''Death Cross'' for first time since April 2020 on Business Standard. The formation occurred in June 2000 when the dot-com bubble burst and again in January 2008 ahead of the global financial crisis

Hopefully, Bitcoin Will Increase Incentive For Cooperation Nasdaq